Morgan Stanley
Real-time prices from Yahoo Finance's public feed. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Latest news
All MS news ›Morgan Stanley Finance LLC ITM Digital Worst Of Barrier Note ACZCHXX (ACZCHXX)
(ACZCHXX) News Headlines Nasdaq Morgan Stanley Finance LLC ITM Digital Worst Of Barrier Note ACZCHXX (ACZCHXX) - Type a symbol or company name. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing…
Morgan Stanley Stock Ahead of Q3 Earnings: Buy, Hold or Sell?
The Globe and Mail Morgan Stanley Stock Ahead of Q3 Earnings: Buy, Hold or Sell? Morgan StanleyMS is set to announce third-quarter 2026 earnings on Oct. 14 before market open. The company’s upcoming financial results and management…
Morgan Stanley Finance LLC ITM Digital Geared Buffer Note ADCICXX (ADCICXX)
(ADCICXX) News Headlines Nasdaq Morgan Stanley Finance LLC ITM Digital Geared Buffer Note ADCICXX (ADCICXX) - Type a symbol or company name. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing…
Chubb (CB) Receives a Hold from Morgan Stanley
Morgan Stanley analyst Bob Huang maintained a Hold rating on Chubb today and set a price target of $350.00. According to TipRanks, Huang is an analyst with an average return of -1.3% and a 50.52% success rate. Huang covers the Financial…
Morgan Stanley (MS) Laps the Stock Market: Here's Why
In the latest trading session, Morgan Stanley (MS) closed at $190.02, marking a +1.38% move from the previous day. This change outpaced the S&P 500's 0.6% gain on the day. Meanwhile, the Dow experienced a rise of 0.83%, and the…
Morgan Stanley Issues a Hold Rating on Amgen (AMGN)
In a report released today, Terence Flynn from Morgan Stanley assigned a Hold rating to Amgen, with a price target of $362.00. Flynn covers the Healthcare sector, focusing on stocks such as BioNTech SE, Merck & Company, and Amgen.…
Merck & Company (MRK) Gets a Buy from Morgan Stanley
In a report released today, Terence Flynn from Morgan Stanley assigned a Buy rating to Merck & Company, with a price target of $179.00. Flynn covers the Healthcare sector, focusing on stocks such as BioNTech SE, Merck & Company, and Amgen.…
Morgan Stanley Keeps Their Buy Rating on Nasdaq (NDAQ)
Morgan Stanley analyst Michael Cyprys maintained a Buy rating on Nasdaq today and set a price target of $118.00. According to TipRanks, Cyprys is a 3-star analyst with an average return of 1.4% and a 49.70% success rate. Cyprys covers the…
Nasdaq price target lowered to $118 from $120 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Nasdaq (NDAQ) to $118 from $120 and keeps an Overweight rating on the shares as part of an ear... Nasdaq price target lowered to $118 from $120 at Morgan Stanley Morgan Stanley lowered the…
Bristol-Myers Squibb (BMY) Gets a Sell from Morgan Stanley
Morgan Stanley analyst Terence Flynn assigned a Sell rating to Bristol-Myers Squibb today and set a price target of $40.00. According to TipRanks, Flynn is a 5-star analyst with an average return of 9.1% and a 58.50% success rate. Flynn…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
tradingview.com1,530
-
marketscreener.com1,138
-
marketbeat.com840
-
theglobeandmail.com777
-
seekingalpha.com722
Measured across the 4Arizona news index. Headline tone is a simple word-based reading of the latest 120 headlines, not a forecast.